共 85 条
[1]
Allahabadia A.(2001)MHC class II region, CTLA-4 gene, and ophthalmopathy in patients with Graves’ disease Lancet 358 984-985
[2]
Heward J.M.(1998)Cigarette smoking and treatment outcomes in Graves’ ophthalmopathy Ann. Intern. Med. 129 632-635
[3]
Nithiyananthan R.(1998)CTLA-4 promoter variants in patients with Graves’ disease and Hashimoto’s thyroiditis Tissue Antigens 51 563-566
[4]
Gibson S.M.(1997)Superoxide radical production stimulates retroocular fibroblast proliferation in Graves’ ophthalmopathy Exp. Eye Res. 65 311-316
[5]
Reuser T.T.(1996)An Msul RFLP in the human CTLA-4 promoter Biochem. Biophys. Res. Commun. 225 817-818
[6]
Dodson P.M.(1997)CTLA-4 alanine-17 confers genetic susceptibility to Graves disease and to type 1 diabetes mellitus J. Clin. Endocrinol. Metab. 82 143-146
[7]
Franklyn J.A.(2001)CTLA-4 gene polymorphisms in Tunisian patients with Graves’ disease Clin. Immunol. 101 361-365
[8]
Gough S.C.L.(1987)Is endocrine ophthalmopathy related to smoking? Br. Med. J. 295 643-645
[9]
Bartalena L.(1998)No evidence for allelic association of a human Clin. Endocrinol. (Oxf) 49 331-334
[10]
Marcocci C.(1999) promoter polymorphism with autoimmune thyroid disease in either population-base case-control or family-based studies Chinese Journal of Endocrinology and Metabolism 15 215-216